位置:首页 > 蛋白库 > NOTC_ASPSM
NOTC_ASPSM
ID   NOTC_ASPSM              Reviewed;         426 AA.
AC   E0Y3X0;
DT   11-DEC-2019, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 1.
DT   03-AUG-2022, entry version 33.
DE   RecName: Full=6-Hydroxy-7-prenyldeoxybrevianamide E synthase notC {ECO:0000303|PubMed:20722388};
DE            EC=2.5.1.- {ECO:0000269|PubMed:20722388};
DE   AltName: Full=Notoamide biosynthesis cluster protein C {ECO:0000303|PubMed:20722388};
DE   AltName: Full=Prenyltransferase notC {ECO:0000303|PubMed:20722388};
GN   Name=notC {ECO:0000303|PubMed:20722388};
OS   Aspergillus sp. (strain MF297-2).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus.
OX   NCBI_TaxID=877550;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, AND PATHWAY.
RC   STRAIN=MF297-2;
RX   PubMed=20722388; DOI=10.1021/ja1049302;
RA   Ding Y., de Wet J.R., Cavalcoli J., Li S., Greshock T.J., Miller K.A.,
RA   Finefield J.M., Sunderhaus J.D., McAfoos T.J., Tsukamoto S., Williams R.M.,
RA   Sherman D.H.;
RT   "Genome-based characterization of two prenylation steps in the assembly of
RT   the stephacidin and notoamide anticancer agents in a marine-derived
RT   Aspergillus sp.";
RL   J. Am. Chem. Soc. 132:12733-12740(2010).
RN   [2]
RP   BIOTECHNOLOGY.
RX   PubMed=17304611; DOI=10.1002/anie.200604381;
RA   Kato H., Yoshida T., Tokue T., Nojiri Y., Hirota H., Ohta T.,
RA   Williams R.M., Tsukamoto S.;
RT   "Notoamides A-D: prenylated indole alkaloids isolated from a marine-derived
RT   fungus, Aspergillus sp.";
RL   Angew. Chem. Int. Ed. 46:2254-2256(2007).
RN   [3]
RP   FUNCTION.
RX   PubMed=22188465; DOI=10.1021/ja2093212;
RA   Li S., Finefield J.M., Sunderhaus J.D., McAfoos T.J., Williams R.M.,
RA   Sherman D.H.;
RT   "Biochemical characterization of NotB as an FAD-dependent oxidase in the
RT   biosynthesis of notoamide indole alkaloids.";
RL   J. Am. Chem. Soc. 134:788-791(2012).
RN   [4]
RP   FUNCTION.
RX   PubMed=23213353; DOI=10.1039/c2md20029e;
RA   Li S., Anand K., Tran H., Yu F., Finefield J.M., Sunderhaus J.D.,
RA   McAfoos T.J., Tsukamoto S., Williams R.M., Sherman D.H.;
RT   "Comparative analysis of the biosynthetic systems for fungal
RT   bicyclo[2.2.2]diazaoctane indole alkaloids: the (+)/(-)-notoamide,
RT   paraherquamide and malbrancheamide pathways.";
RL   Med. Chem. Commun. 3:987-996(2012).
CC   -!- FUNCTION: Prenyltransferase; part of the gene cluster that mediates the
CC       biosynthesis of notoamide, a fungal indole alkaloid that belongs to a
CC       family of natural products containing a characteristic
CC       bicyclo[2.2.2]diazaoctane core (PubMed:20722388). The first step of
CC       notoamide biosynthesis involves coupling of L-proline and L-tryptophan
CC       by the bimodular NRPS notE, to produce cyclo-L-tryptophan-L-proline
CC       called brevianamide F (PubMed:20722388). The reverse prenyltransferase
CC       notF then acts as a deoxybrevianamide E synthase and converts
CC       brevianamide F to deoxybrevianamide E via reverse prenylation at C-2 of
CC       the indole ring leading to the bicyclo[2.2.2]diazaoctane core
CC       (PubMed:20722388). Deoxybrevianamide E is further hydroxylated at C-6
CC       of the indole ring, likely catalyzed by the cytochrome P450
CC       monooxygenase notG, to yield 6-hydroxy-deoxybrevianamide E (Probable).
CC       6-hydroxy-deoxybrevianamide E is a specific substrate of the
CC       prenyltransferase notC for normal prenylation at C-7 to produce 6-
CC       hydroxy-7-prenyl-deoxybrevianamide, also called notoamide S
CC       (PubMed:20722388). As the proposed pivotal branching point in notoamide
CC       biosynthesis, notoamide S can be diverted to notoamide E through an
CC       oxidative pyran ring closure putatively catalyzed by either notH
CC       cytochrome P450 monooxygenase or the notD FAD-linked oxidoreductase
CC       (Probable). This step would be followed by an indole 2,3-epoxidation-
CC       initiated pinacol-like rearrangement catalyzed by the notB FAD-
CC       dependent monooxygenase leading to the formation of notoamide C and
CC       notoamide D (PubMed:22188465). On the other hand notoamide S is
CC       converted to notoamide T by notH (or notD), a bifunctional oxidase that
CC       also functions as the intramolecular Diels-Alderase responsible for
CC       generation of (+)-notoamide T (Probable). To generate antipodal (-)-
CC       notoaminide T, notH' (or notD') in Aspergillus versicolor is expected
CC       to catalyze a Diels-Alder reaction leading to the opposite
CC       stereochemistry (Probable). The remaining oxidoreductase notD (or notH)
CC       likely catalyzes the oxidative pyran ring formation to yield (+)-
CC       stephacidin A (Probable). The FAD-dependent monooxygenase notI is
CC       highly similar to notB and is predicted to catalyze a similar
CC       conversion from (+)-stephacidin A to (-)-notoamide B via the 2,3-
CC       epoxidation of (+)-stephacidin A followed by a pinacol-type
CC       rearrangement (Probable). Finally, it remains unclear which enzyme
CC       could be responsible for the final hydroxylation steps leading to
CC       notoamide A and sclerotiamide (Probable). {ECO:0000269|PubMed:20722388,
CC       ECO:0000269|PubMed:22188465, ECO:0000305|PubMed:23213353}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=6-hydroxydeoxybrevianamide E + dimethylallyl diphosphate =
CC         diphosphate + notoamide S; Xref=Rhea:RHEA:62344, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57623, ChEBI:CHEBI:145682, ChEBI:CHEBI:145683;
CC         Evidence={ECO:0000269|PubMed:20722388};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62345;
CC         Evidence={ECO:0000269|PubMed:20722388};
CC   -!- ACTIVITY REGULATION: Addition of 5 mM Mg(2+), Ca(2+) or Mn(2+) slightly
CC       enhances catalysis (about 100-120%) (PubMed:20722388). Significant
CC       reduction of enzyme activity (2%-35%) is observed with Cu(2+), Zn(2+),
CC       Fe(2+), or Sn(2+) (5 mM) (PubMed:20722388).
CC       {ECO:0000269|PubMed:20722388}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.64 uM for 6-hydroxy-deoxybrevianamide E
CC         {ECO:0000269|PubMed:20722388};
CC         KM=1.89 uM for dimethylallyl diphosphate (DMAPP)
CC         {ECO:0000269|PubMed:20722388};
CC         Vmax=1.18 uM/min/mg enzyme toward dimethylallyl diphosphate (DMAPP)
CC         {ECO:0000269|PubMed:20722388};
CC         Vmax=1.45 uM/min/mg enzyme toward 6-hydroxy-deoxybrevianamide E
CC         {ECO:0000269|PubMed:20722388};
CC       pH dependence:
CC         Optimum pH is 6-9. {ECO:0000269|PubMed:20722388};
CC       Temperature dependence:
CC         Optimum temperature is 16 to 42 degrees Celsius.
CC         {ECO:0000269|PubMed:20722388};
CC   -!- PATHWAY: Alkaloid biosynthesis. {ECO:0000269|PubMed:20722388}.
CC   -!- BIOTECHNOLOGY: Notoamides have been shown to exhibit antitumoral
CC       activities (PubMed:17304611). Notoamides A-C show moderate cytotoxicity
CC       against HeLa and L1210 cells with IC(50) values in the range of 22-52
CC       mg/ml, but the IC(50) value of notoamide D is greater than 100 mg/ml
CC       (PubMed:17304611). Moreover, notoamide C induces G2/M-cell cycle arrest
CC       at a concentration of 6.3 mg/ml (PubMed:17304611).
CC       {ECO:0000269|PubMed:17304611}.
CC   -!- SIMILARITY: Belongs to the tryptophan dimethylallyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GU564534; ADM34131.1; -; Genomic_DNA.
DR   EMBL; HM622670; ADM34136.1; -; Genomic_DNA.
DR   AlphaFoldDB; E0Y3X0; -.
DR   SMR; E0Y3X0; -.
DR   BioCyc; MetaCyc:MON-19051; -.
DR   GO; GO:0004659; F:prenyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0009820; P:alkaloid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0044249; P:cellular biosynthetic process; IEA:UniProt.
DR   GO; GO:1901576; P:organic substance biosynthetic process; IEA:UniProt.
DR   CDD; cd13929; PT-DMATS_CymD; 1.
DR   InterPro; IPR033964; Aro_prenylTrfase.
DR   InterPro; IPR017795; Aro_prenylTrfase_DMATS.
DR   InterPro; IPR012148; DMATS-type_fun.
DR   PANTHER; PTHR40627; PTHR40627; 1.
DR   Pfam; PF11991; Trp_DMAT; 1.
DR   PIRSF; PIRSF000509; Trp_DMAT; 1.
DR   SFLD; SFLDS00036; Aromatic_Prenyltransferase; 1.
DR   TIGRFAMs; TIGR03429; arom_pren_DMATS; 1.
PE   1: Evidence at protein level;
KW   Alkaloid metabolism; Prenyltransferase; Transferase.
FT   CHAIN           1..426
FT                   /note="6-Hydroxy-7-prenyldeoxybrevianamide E synthase notC"
FT                   /id="PRO_0000448809"
FT   BINDING         94
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         105
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         191
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         193
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         195
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         267
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         269
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         352
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         354
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         418
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
FT   BINDING         422
FT                   /ligand="dimethylallyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:57623"
FT                   /evidence="ECO:0000250|UniProtKB:Q4WAW7"
SQ   SEQUENCE   426 AA;  49102 MW;  E876B32D1957A3CD CRC64;
     MAIEEKSTSA EPGPYDALSR FSSLTGEDDR KWWEHTGPVL EKVMRDSGYE LQSQYIYLYF
     VQQHLIPYLG KFPTRGQDDH RWQSNLTPYK VPYELSWNVS HKVVRISWDP VCDASGTEND
     AFNKKAIHDC TRQLAELDST VILDRYRLLH KDLVITDEEE QQLLRRDVLP KSGRGQHNLA
     VDFQEGGITL KVYFYPYMKF LATGTPIEEL FFSAIEKLRI ADIDEAVGML KCFLSPKSDD
     GKPSVDEKVF PSLLACDLCD PSKSRIKYYV IDKWVKWERI ANLWTIGGRR LEDPYCAKGL
     ALLKELWDLL AIPEGDRGDI WPNLVLGQPP THLMTTIANY TLSPASRFPE PQVYLTTFGL
     NDMAIIDALT AFYERVGFTD MAKSYKKNVQ SYYPNLDLNQ TNWVHEAVSF SYRNSKPYLS
     VYYSPF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024